EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1 ‐ or IDH2 ‐mutant newly diagnosed acute myeloid leukemia—A multicenter cohort study

Jan Philipp Bewersdorf iD, Shai Shimony iD, Rory M Shallis, Yiwen Liu, Guillaume Berton iD, Eva J Schaefer, Amer M Zeidan, Aaron Goldberg, Eytan Stein, Guido Marcucci, Rebecca P Bystrom, R Coleman Lindsley und 11 weitere

American Journal of Hematology · 2024-08 · 99 (8) · 1640-1643

DOI: 10.1002/ajh.27366 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift American Journal of Hematology, online erschienen am 15.05.2024. Verfasst von Jan Philipp Bewersdorf und 22 weiteren Autor:innen. Beteiligte Einrichtung: Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Bridged Bicyclo Compounds, Heterocyclic, Induction Chemotherapy, Isocitrate Dehydrogenase. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 6 Literaturangaben. Gefördert von: National Institute of Health, National Institutes of Health/National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Combined Chemotherapy ProtocolsBridged Bicyclo Compounds, HeterocyclicInduction ChemotherapyIsocitrate DehydrogenaseLeukemia, Myeloid, AcuteMutationSulfonamidesAdultAgedFemaleHumansMaleMiddle AgedCohort Studies

Substanzen

Bridged Bicyclo Compounds, HeterocyclicIDH1 protein, humanIDH2 protein, humanIsocitrate DehydrogenaseSulfonamidesvenetoclax

Autor:innen und Institutionen

  • Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Department of Medical Oncology, Division of Leukemia, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Hematology Section, Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, Connecticut, USA.
  • Data Science, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Hematology Department, Aix-Marseille Université, Inserm U1068, CNRS UMR7258, Institut Paoli-Calmettes, Centre de Recherche en Cancérologie de Marseille (CRCM), Marseille, France.
  • Department of Medical Oncology, National Center for Tumor Diseases (NCT), Heidelberg, Germany.

ORCID-Profile: Jan Philipp Bewersdorf, Shai Shimony, Guillaume Berton, Vinod Pullarkat, Ibrahim Aldoss, Donna S Neuberg, Sylvain Garciaz, Brian Ball

Förderung

  • National Institute of Health
  • National Institutes of Health/National Cancer Institute

Zitieren

APA

Bewersdorf, J. P., Shimony, S., Shallis, R. M., Liu, Y., Berton, G., Schaefer, E. J., Zeidan, A. M., Goldberg, A., Stein, E., Marcucci, G., Bystrom, R. P., Lindsley, R. C., Chen, E. C., Ramos, J., Stein, A., Pullarkat, V., Aldoss, I., DeAngelo, D. J., Neuberg, D. S., …, & Stahl, M. (2024). Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1 ‐ or IDH2 ‐mutant newly diagnosed acute myeloid leukemia—A multicenter cohort study. American Journal of Hematology, 99(8), 1640-1643. https://doi.org/10.1002/ajh.27366

Vancouver

Bewersdorf JP, Shimony S, Shallis RM, Liu Y, Berton G, Schaefer EJ, et al. Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1 ‐ or IDH2 ‐mutant newly diagnosed acute myeloid leukemia—A multicenter cohort study. American Journal of Hematology. 2024;99(8):1640-1643. doi:10.1002/ajh.27366

BibTeX
@article{Bewersdorf2024,
  author = {Bewersdorf, Jan Philipp and Shimony, Shai and Shallis, Rory M and Liu, Yiwen and Berton, Guillaume and Schaefer, Eva J and Zeidan, Amer M and Goldberg, Aaron and Stein, Eytan and Marcucci, Guido and Bystrom, Rebecca P and Lindsley, R Coleman and Chen, Evan C and Ramos, Jorge and Stein, Anthony and Pullarkat, Vinod and Aldoss, Ibrahim and DeAngelo, Daniel J and Neuberg, Donna S and Stone, Richard M and Garciaz, Sylvain and Ball, Brian and Stahl, Maximilian},
  title = {Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1 ‐ or IDH2 ‐mutant newly diagnosed acute myeloid leukemia—A multicenter cohort study},
  journal = {American Journal of Hematology},
  year = {2024},
  volume = {99},
  number = {8},
  pages = {1640--1643},
  doi = {10.1002/ajh.27366}
}
Kostenlos starten →